Nonmetabolic complications of neonatal intravenous therapy: epidemiologic considerations.
D000038:Abscess / Q000150:complications / Q000209:etiology / Q000382:microbiology; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001034:Apgar Score; D001724:Birth Weight; D002481:Cellulitis / Q000150:complications / Q000209:etiology; D004927:Escherichia coli Infections / Q000382:microbiology; D006801:Humans; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000209:etiology*; D007263:Infusions, Parenteral / Q000009:adverse effects*; D007710:Klebsiella Infections / Q000382:microbiology; D018805:Sepsis / Q000150:complications / Q000209:etiology / Q000382:microbiology; D012867:Skin / Q000473:pathology; D013203:Staphylococcal Infections / Q000382:microbiology; D013924:Thrombophlebitis / Q000150:complications / Q000209:etiology
D000900:Anti-Bacterial Agents